Silodosin versus tamsulosin in symptomatic benign prostatic hyperplasia-Our experience

Apply

 Silodosin versus tamsulosin in symptomatic benign prostatic hyperplasia-Our experience

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2015, Vol 5, Issue 6

Abstract

 Abstract : Aim: Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in elderly men. Selective alfa 1 -adrenergic antagonists are now first-line drugs in the medical management of BPH. We conducted randomized, controlled trial to compare the effectiveness and safety of the new alfa 1 -blocker silodosin versus the established drug tamsulosin in symptomatic BPH. Materials and Methods: Ambulatory male BPH patients, aged above 50 years, were recruited on the basis of International Prostate Symptom Score (IPSS). Subjects were randomized in 1:1 ratio to receive either tamsulosin 0.4 mg controlled release or silodosin 8 mg once daily after dinner for 12-week. Primary outcome measure was reduction in IPSS. Proportion of subjects who achieved IPSS <8, change in prostate size as assessed by ultrasonography and changes in peak urine flow rate and allied uroflowmetry parameters, were secondary effectiveness variables. Treatment emergent adverse events were recorded. Results: Data of 57 subjects - 28 on silodosin and 29 on tamsulosin were analyzed. Final IPSS at 12-week was significantly less than baseline for both groups. However, groups remained comparable in terms of IPSS at all visits. There was a significant impact on sexual function (assessed by IPSS sexual function score) in silodosin arm compared with tamsulosin. Prostate size and uroflowmetry parameters did not change. Both treatments were well-tolerated. Retrograde ejaculation was encountered only with silodosin and postural hypotension only with tamsulosin. Conclusions: Silodosin is comparable to tamsulosin in the treatment of BPH in Indian men. However, retrograde ejaculation may be troublesome for sexually active patients

Authors and Affiliations

B. Natarajan, Yogesh Kalra

Keywords

Chromogenic Spectrophotometric Estimation of Brivaracetam in Bulk drug & its Formulation with Folin Ciocalteu reagent

Simple, precise, economic & less time consuming visible spectroscopic method for Brivaracetam was developed by using Folin Ciocalteu Reagent (FCR) in the presence of base. The absorption maximum of the chromogen was foun...

In vivo antiplasmodial activity of crude extracts of Vernonia cinerea Less (Asteraceae) against Plasmodium berghei infection in mice in Bobo-Dioulasso, Burkina Faso.

Resistance of Plasmodium falciparum against antimalarial drugs constitutes a veritable obstacle to malarial control in the world and particularly in Sub-Saharan Africa. Nowadays the artemisinin resistance was observed in...

EP ID EP111434
DOI -
Views 93
Downloads 0